Keywords: corcept, corlux, reduces, psychotic, features, mdd, usa

Corcept's Corlux reduces psychotic features of MDD

Article | 14 August 2006

The USA's Corcept Therapeutics says that recently-published Phase II clinical trail data demonstrate with statistical significance that more patients treated ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Mifeprex

Mifepristone

Go to drug listing